Commercial Aquaculture Vaccines Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032

Report code : IS1459, Status : Published, Published on: Apr, 2023, Pages : 151 Pages, Format : PDF/PPT/Excel

Buying Options

Global Analysis: : $999

Global and Regional Analysis : $2799

Global Deep Dive Analysis : $5499

Competition Analysis : $399

Buy Now

Enquiry before buying

Description

The global Commercial Aquaculture Vaccines market size was estimated to be US$ 272.91 Million in 2022 and is expected to grow at a CAGR of 7.4% between 2023 to 2032.

Commercial Aquaculture Vaccines refer to vaccines that are specifically developed for use in aquaculture to prevent or reduce the incidence of diseases in farmed fish and shellfish. Aquatic diseases can cause significant economic losses for the aquaculture industry, and vaccines are an important tool for disease prevention and management.

Commercial Aquaculture Vaccines are produced using various technologies, including inactivated, live attenuated, subunit, and DNA-based vaccines, and are designed to protect against specific diseases that are common in farmed fish and shellfish. These vaccines are administered to fish and shellfish through various routes, including injection, immersion, and oral administration, depending on the specific vaccine and species.

The use of Commercial Aquaculture Vaccines has become increasingly common in the aquaculture industry as a means of promoting healthier, more sustainable, and more profitable aquaculture operations.

Commercial Aquaculture Vaccines Market Drivers

The global commercial aquaculture vaccines market is being driven by several factors. Firstly, the rising prevalence of aquatic diseases, such as bacterial infections and parasitic infections, has led to an increased demand for commercial aquaculture vaccines. Diseases can result in significant losses to the aquaculture industry, highlighting the importance of preventive measures such as vaccination.

Secondly, growing investment in the aquaculture industry, both from governments and private organizations, is leading to increased production of fish and seafood. This increase in production is expected to boost demand for commercial aquaculture vaccines as preventive measures.

Finally, the increasing demand for seafood products, driven by a growing population, changing dietary habits, and rising disposable income, is driving the growth of the aquaculture industry, which in turn is driving the demand for commercial aquaculture vaccines.

These factors are interlinked, and as the demand for seafood products increases, the production of fish and seafood is expected to increase as well, which will lead to a further demand for commercial aquaculture vaccines. This market is expected to continue growing due to favorable government regulations, technological advancements, and increasing consumer awareness of food safety.

Companies operating in this market are expected to invest in research and development to meet the growing demand for effective and safe commercial aquaculture vaccines.

Species Segmentation of Global Commercial Aquaculture Vaccines Market

Salmon segment is the largest segment in the market

Based on species, the salmon segment is one of the largest segments in the market due to the high demand for farmed salmon and the prevalence of diseases that affect the species. Salmon is one of the most widely farmed species in the world and is known to be susceptible to a range of viral and bacterial diseases, such as Infectious Salmon Anemia (ISA), Salmonid Rickettsial Septicaemia (SRS), and Pancreas Disease (PD), among others.

These diseases can cause significant economic losses for salmon farmers due to mortality, reduced growth rates, and decreased production. Therefore, disease prevention measures such as vaccines are crucial for the sustainable growth of the salmon industry.

Several commercial aquaculture vaccines are available for salmon, including inactivated, live attenuated, and recombinant vaccines. For example, a recombinant vaccine for ISA in salmon was recently developed and is currently in use in Norway, which is one of the largest producers of farmed salmon in the world.

The use of vaccines has helped reduce the incidence of diseases in salmon farms, leading to increased production and profitability. Other species such as tilapia, carp, and catfish are also important segments in the Global Commercial Aquaculture Vaccines Market, and the demand for vaccines for these species is expected to increase as the aquaculture industry continues to grow and expand globally.

Regional Trends of the Global Commercial Aquaculture Vaccines Market

Increasing demand for seafood is driving the growth of the market in North America

Geographically, the global commercial aquaculture vaccines market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America.

Following are some of the major trends in these regions –

North America: The North American market for commercial aquaculture vaccines is driven by the presence of large aquaculture industries in the US and Canada, particularly for species such as salmon, trout, and catfish.

The increasing demand for seafood and the need for disease prevention measures are driving the growth of the market. Additionally, the region has a well-developed regulatory framework for the approval and use of commercial aquaculture vaccines.

Europe: The European market for commercial aquaculture vaccines is driven by the high demand for farmed salmon, trout, and carp. The region has a strong regulatory framework for aquaculture production and is focused on promoting sustainable aquaculture practices.

The increasing focus on animal welfare and environmental sustainability is driving the demand for safe and effective disease prevention measures such as vaccines.

Asia-Pacific: The Asia-Pacific market for commercial aquaculture vaccines is driven by the high demand for seafood products, particularly in countries such as China, India, and Indonesia. The region is also the largest producer of farmed fish and shellfish in the world, and diseases are a significant concern for aquaculture production. The increasing adoption of advanced technologies and the development of new vaccines are driving the growth of the market.

Middle East and Africa: The Middle East and Africa market for commercial aquaculture vaccines is driven by the increasing demand for seafood products and the need to reduce the reliance on wild-capture fisheries. The region has a growing aquaculture industry, particularly for species such as tilapia and catfish, and disease prevention measures such as vaccines are becoming increasingly important for sustainable production.

South America: The South American market for commercial aquaculture vaccines is driven by the large aquaculture industries in countries such as Chile, Brazil, and Ecuador. The increasing demand for farmed salmon and shrimp and the prevalence of diseases that affect these species are driving the growth of the market. Additionally, the region has a favorable regulatory environment for the approval and use of commercial aquaculture vaccines.

Key players and market strategies:

The major growth strategies adopted by companies operating in the Global Commercial Aquaculture Vaccines Market include:

Product development and innovation: Companies are investing in research and development to develop new and effective vaccines that can prevent a range of diseases in different species of fish and shellfish.

Strategic partnerships and collaborations: Companies are forming partnerships with other companies, research institutes, and universities to share knowledge and resources, accelerate product development, and expand their market reach.

Geographic expansion: Companies are expanding their operations to new regions, particularly in developing countries with large aquaculture industries, to tap into the growing demand for commercial aquaculture vaccines.

Mergers and acquisitions: Companies are acquiring or merging with other companies to expand their product portfolios, increase their market share, and improve their competitive position.

Marketing and branding: Companies are investing in marketing and branding to increase awareness of their products and build brand loyalty among customers.

AB Vista, AniCon Labor GmbH, Benchmark Holdings Plc, Hipra, Merck & Co., Inc., Nisseiken Co., Ltd., Novartis International AG, Pfizer Inc., PHARMAQ AS, Tecnovax SA, Vaxxinova GmbH, Vetanco, Virbac, Zoetis Inc., Zydus Animal Health and many more.

Global Commercial Aquaculture Vaccines Market Segmentation:

By Vaccine Type:

Inactivated vaccines
Live attenuated vaccines
Recombinant vaccines
Others

By Species:

By Administration:

Oral vaccines
Injection vaccines
Immersion vaccines

By Region

North America
- United States
- Canada
- Rest of North America
Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- India
- China
- Australia
- South Korea
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
South America
- Brazil
- Rest of South America

Table Of Content

Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
Market Synopsis: Global Commercial Aquaculture Vaccines Market
Global Commercial Aquaculture Vaccines Market Qualitative Analysis
- Trends
  - Market trends
  - Technology Trends
- PESTLE Analysis (For 3 prominent countries)
- Market Influencers
  - Driving Forces
  - Hindering Forces
  - Opportunities
- COVID-19 impact
- Porter’s Five Forces Analysis
- Value Chain Analysis
Global Commercial Aquaculture Vaccines Market Analysis and Forecast, by Vaccine Type
- Overview and definitions
- Key segment analysis
- Global Commercial Aquaculture Vaccines Market Estimates (US$ Mn), Vaccine Type, 2019 – 2032
  - Inactivated vaccines
  - Live attenuated vaccines
  - Recombinant vaccines
  - Others

Global Commercial Aquaculture Vaccines Market Analysis and Forecast, by Species
- Overview and definitions
- Key segment analysis
- Global Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Species, 2019 – 2032
  - Salmon
  - Tilapia
  - Carp
  - Trout
  - Catfish
  - Others

Global Commercial Aquaculture Vaccines Market Analysis and Forecast, by Route of Administration
- Overview and definitions
- Key segment analysis
- Global Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Route of Administration, 2019 – 2032
  - Oral vaccines
  - Injection vaccines
  - Immersion vaccines

Global Commercial Aquaculture Vaccines Market Analysis and Forecast, by End Use
- Overview and definitions
- Key segment analysis
- Global Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Fish Farming Companies
  - Fish Veterinary Clinics
  - Aquatic Research Institute

Global Commercial Aquaculture Vaccines Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Region, 2019 – 2032
  - North America
  - Europe
  - Asia Pacific
  - Middle East & Africa
  - South America

North America Commercial Aquaculture Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), Vaccine Type, 2019 – 2032
  - Inactivated vaccines
  - Live attenuated vaccines
  - Recombinant vaccines
  - Others
- North America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Species, 2019 – 2032
  - Salmon
  - Tilapia
  - Carp
  - Trout
  - Catfish
  - Others
- North America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Route of Administration, 2019 – 2032
  - Oral vaccines
  - Injection vaccines
  - Immersion vaccines
- North America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Fish Farming Companies
  - Fish Veterinary Clinics
  - Aquatic Research Institute
- North America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
  - United States
  - Canada
  - Rest of North America

Europe Commercial Aquaculture Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Commercial Aquaculture Vaccines Market Estimates (US$ Mn), Vaccine Type, 2019 – 2032
  - Inactivated vaccines
  - Live attenuated vaccines
  - Recombinant vaccines
  - Others
- Europe Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Species, 2019 – 2032
  - Salmon
  - Tilapia
  - Carp
  - Trout
  - Catfish
  - Others
- Europe Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Route of Administration, 2019 – 2032
  - Oral vaccines
  - Injection vaccines
  - Immersion vaccines
- Europe Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Fish Farming Companies
  - Fish Veterinary Clinics
  - Aquatic Research Institute
- Europe Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
  - Germany
  - United Kingdom
  - Italy
  - France
  - Spain
  - Rest of Europe

Asia Pacific Commercial Aquaculture Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Commercial Aquaculture Vaccines Market Estimates (US$ Mn), Vaccine Type, 2019 – 2032
  - Inactivated vaccines
  - Live attenuated vaccines
  - Recombinant vaccines
  - Others
- Asia Pacific Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Species, 2019 – 2032
  - Salmon
  - Tilapia
  - Carp
  - Trout
  - Catfish
  - Others
- Asia Pacific Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Route of Administration, 2019 – 2032
  - Oral vaccines
  - Injection vaccines
  - Immersion vaccines
- Asia Pacific Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Fish Farming Companies
  - Fish Veterinary Clinics
  - Aquatic Research Institute
- Asia Pacific Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
  - China
  - Japan
  - South Korea
  - India
  - Australia
  - Rest of Asia Pacific

Middle East & Africa Commercial Aquaculture Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Commercial Aquaculture Vaccines Market Estimates (US$ Mn), Vaccine Type, 2019 – 2032
  - Inactivated vaccines
  - Live attenuated vaccines
  - Recombinant vaccines
  - Others
- Middle East & Africa Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Species, 2019 – 2032
  - Salmon
  - Tilapia
  - Carp
  - Trout
  - Catfish
  - Others
- Middle East & Africa Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Route of Administration, 2019 – 2032
  - Oral vaccines
  - Injection vaccines
  - Immersion vaccines
- Middle East & Africa Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Fish Farming Companies
  - Fish Veterinary Clinics
  - Aquatic Research Institute
- Middle East & Africa Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
  - UAE
  - Saudi Arabia
  - South Africa
  - Israel
  - Rest of MEA

South America Commercial Aquaculture Vaccines Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), Vaccine Type, 2019 – 2032
  - Inactivated vaccines
  - Live attenuated vaccines
  - Recombinant vaccines
  - Others
- South America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Species, 2019 – 2032
  - Salmon
  - Tilapia
  - Carp
  - Trout
  - Catfish
  - Others
- South America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Route of Administration, 2019 – 2032
  - Oral vaccines
  - Injection vaccines
  - Immersion vaccines
- South America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Fish Farming Companies
  - Fish Veterinary Clinics
  - Aquatic Research Institute
- South America Commercial Aquaculture Vaccines Market Estimates (US$ Mn), by Country, 2019 – 2032
  - Brazil
  - Argentina
  - Rest of South America

Competition Analysis – Global Commercial Aquaculture Vaccines Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
  - AB Vista
    - Business overview
    - Geographic presence
    - Product portfolio
    - Financial facts
    - Relevant news and strategic view
  - AniCon Labor GmbH
  - Benchmark Holdings Plc
  - Hipra
  - Merck & Co., Inc.
  - Nisseiken Co., Ltd.
  - Novartis International AG
  - Pfizer Inc.
  - PHARMAQ AS
  - Tecnovax SA
  - Vaxxinova GmbH
  - Vetanco
  - Virbac
  - Zoetis Inc.
  - Zydus Animal Health

Conclusion & Recommendations

Request Sample

Request for Customization

Call with the Author

Frequently asked questions about this report

How large is the commercial aquaculture vaccines market?

The commercial aquaculture vaccines market size was estimated to be US$ 272.91 Million in 2022.

How much is the commercial aquaculture vaccines market growth?

The commercial aquaculture vaccines market is expected grow at a CAGR of 7.4% between 2023 to 2032.

What are the major drivers for the global commercial aquaculture vaccines market?

The global commercial aquaculture vaccines market is being driven by the rising prevalence of aquatic diseases, such as bacterial infections and parasitic infections and growing investment in the aquaculture industry, both from governments and private organizations, is leading to increased production of fish and seafood.

How is the regional performance of the commercial aquaculture vaccines market?

The North American market for commercial aquaculture vaccines is driven by the presence of large aquaculture industries in the US and Canada, particularly for species such as salmon, trout, and catfish.

What are the key growth strategies of commercial aquaculture vaccines industry players?

The major growth strategies adopted by these companies are investing in marketing and branding to increase awareness of their products and build brand loyalty among customers.

Which species type is the largest in the commercial aquaculture vaccines market?

Based on species, the salmon segment is one of the largest segments in the market due to the high demand for farmed salmon and the prevalence of diseases that affect the species.